360 High-Risk Vulnerability Immunization Tool V2.0 vs HarfangLab EPP Antivirus: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

HarfangLab EPP Antivirus: EPP antivirus with signature-based and behavioral malware detection. built by HarfangLab. Core capabilities include Signature-based malware detection using IKARUS engine, Behavioral analysis and heuristics, Multi-OS support for Windows, MacOS, and Linux..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. HarfangLab EPP Antivirus differentiates with Signature-based malware detection using IKARUS engine, Behavioral analysis and heuristics, Multi-OS support for Windows, MacOS, and Linux.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). HarfangLab EPP Antivirus is developed by HarfangLab. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and HarfangLab EPP Antivirus serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.